In vitro evaluation of experimental agents for anti-HIV activity (Q39989119)

16 September 2017

title

In vitro evaluation of experimental agents for anti-HIV activity (English)

1 reference

16 September 2017

0 references

D D Richman

1

1 reference

16 September 2017

V A Johnson

2

1 reference

16 September 2017

D M Mayers

3

1 reference

16 September 2017

T Shirasaka

4

1 reference

16 September 2017

M C O'Brien

5

1 reference

16 September 2017

H Mitsuya

6

1 reference

16 September 2017

publication date

1 May 2001

1 reference

Current Protocols in Immunology

16 September 2017

published in

1 reference

16 September 2017

volume

Chapter 12

1 reference

16 September 2017

page(s)

Unit 12.9

1 reference

The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Designing CD4 immunoadhesins for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

HIV inhibitors targeted at the reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

The role of mononuclear phagocytes in HTLV-III/LAV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Molecular targets for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Detection of Mutations Associated with Zidovudine Resistance in Human Immunodeficiency Virus by Use of the Polymerase Chain Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Present Status and Future Prospects for HIV Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142735.IM1209S08

10.1002/0471142735.IM1209S08

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference